TB-500: actin sequestration and cell migration TB-500 is the synthetic name commonly applied to the LKKTETQ-containing fragment of Thymosin Beta-4 (Tb4), a 43-amino-acid actin-sequestering peptide present in nearly every mammalian cell type
Adverse effects observed in trials to date include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (common with GLP-1 receptor agonists) Reduced appetite and weight loss , which may be excessive in some individuals Elevated heart rate , a concern noted with glucagon receptor agonism As with other incretin-based therapies, there is also a class-level signal for acute pancreatitis and gallbladder disease (including cholelithiasis and cholecystitis)
It cannot replace controlled human trials showing that patients feel, function, and remain healthier with acceptable risk
Energy and overall vitality Anti-aging peptide therapy doesnt just improve your appearance
Zepbound, developed by Eli Lilly and Co., is already approved as Mounjaro for improving blood sugar in adults with type 2 diabetes
